Browsing Artículos (Medicina) by Subject "Lanifibranor"
Now showing items 1-1 of 1
-
Article
A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH
(Massachusetts Medical Society, 2021)BACKGROUND Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need. Lanifibranor is a pan-PPAR ...